计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| G173905-1mg |
1mg |
现货 ![]() |
| |
| G173905-5mg |
5mg |
现货 ![]() |
| |
| G173905-10mg |
10mg |
现货 ![]() |
| |
| G173905-25mg |
25mg |
现货 ![]() |
| |
| G173905-50mg |
50mg |
现货 ![]() |
| |
| G173905-100mg |
100mg |
现货 ![]() |
|
| 别名 | 伊比鲁司他 |
|---|---|
| 英文别名 | HY-16743 | SCHEMBL12615329 | DB14966 | Ibiglustat | (S)-Quinuclidin-3-yl(2-(2-(4-fluorophenyl)thiazol-4-yl)propan-2-yl)carbamate | Venglustat (USAN/INN) | GTPL11550 | GZ/SAR402671 | GZ/SAR-402671 | SAR402671 | SAR-402671 | D11633 | EN300-17267 | Ibiglusta |
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | Ibiglustat |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | 神经酰胺葡萄糖基转移酶抑制剂 |
| 产品介绍 |
Ibiglustat (Venglustat) 是一种具有口服活性的,可透过血脑屏障的葡萄糖神经酰胺合成酶 (GCS) 抑制剂。Ibiglustat 可用于研究戈谢病 3 型、与 GBA 突变相关的帕金森病、法布瑞氏症、GM2 神经节苷脂病和常染色体显性多囊肾病。 Ibiglustat (Venglustat) is a glucose ceramide synthase (GCS) inhibitor with oral activity that can penetrate the blood-brain barrier. Ibiglustat can be used to study Goecher's disease type 3, Parkinson's disease associated with GBA mutations, Fabry's disease, GM2 gangliosis, and autosomal dominant polycystic kidney disease. |
| 纯度 | ≥98% |
| ALogP | 3.5 |
|---|
| 活性类型 | Relation | Activity value | Units | Action Type | 期刊 | PubMed Id | doi | Assay Aladdin ID |
|---|
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | [(3S)-1-azabicyclo[2.2.2]octan-3-yl] N-[2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl]carbamate |
| INCHI | 1S/C20H24FN3O2S/c1-20(2,17-12-27-18(22-17)14-3-5-15(21)6-4-14)23-19(25)26-16-11-24-9-7-13(16)8-10-24/h3-6,12-13,16H,7-11H2,1-2H3,(H,23,25)/t16-/m1/s1 |
| InChi Key | YFHRCLAKZBDRHN-MRXNPFEDSA-N |
| Smiles | CC(C)(C1=CSC(=N1)C2=CC=C(C=C2)F)NC(=O)OC3CN4CCC3CC4 |
| Isomeric SMILES | CC(C)(C1=CSC(=N1)C2=CC=C(C=C2)F)NC(=O)O[C@@H]3CN4CCC3CC4 |
| 分子量 | 389.49 |
| Reaxy-Rn | 27448625 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=27448625&ln= |
| 分子量 | 389.500 g/mol |
|---|---|
| XLogP3 | 3.500 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 6 |
| 可旋转键计数Rotatable Bond Count | 5 |
| 精确质量Exact Mass | 389.157 Da |
| 单同位素质量Monoisotopic Mass | 389.157 Da |
| 拓扑极表面积Topological Polar Surface Area | 82.700 Ų |
| 重原子数Heavy Atom Count | 27 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 533.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 1 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 1. Vitner EB, Achdout H, Avraham R, Politi B, Cherry L, Tamir H, Yahalom-Ronen Y, Paran N, Melamed S, Erez N et al.. (2021) Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and Influenza virus.. J Biol Chem, (100470). [PMID:33639165] [10.1016/j.jbc.2021.100470] |
| 2. Wilson MW, Shu L, Hinkovska-Galcheva V, Jin Y, Rajeswaran W, Abe A, Zhao T, Luo R, Wang L, Wen B et al.. (2020) Optimization of Eliglustat-Based Glucosylceramide Synthase Inhibitors as Substrate Reduction Therapy for Gaucher Disease Type 3.. ACS Chem Neurosci, 11 (20): (3464-3473). [PMID:33035424] |
| 3. Dong G, Deng Y, Yasgar A, Yadav R, Talley D, Zakharov AV, Jain S, Rai G, Noinaj N, Simeonov A et al.. (2022) Venglustat Inhibits Protein N-Terminal Methyltransferase 1 in a Substrate-Competitive Manner.. J Med Chem, [PMID:36074125] [10.1021/acs.jmedchem.2c01050] |
| 4. Schneider SA, Alcalay RN. (2020) Precision medicine in Parkinson's disease: emerging treatments for genetic Parkinson's disease.. J Neurol, 267 (3): (860-869). [PMID:31974807] |
| 5. van der Veen SJ, Hollak CEM, van Kuilenburg ABP, Langeveld M. (2020) Developments in the treatment of Fabry disease.. J Inherit Metab Dis, 43 (5): (908-921). [PMID:32083331] |